A method for synthesizing probes for detecting Hepatitis B virus DNA in serum was developed. It uses DNA extracted from the serum of an Hepatitis B virus carrier äs target, and digoxigenin-11-dUTP incorporated in | DNA sequences during the polymerase chain reaction äs tracer. j ; Using a Spot hybridization assay, the sensitivity and specificity of the digoxigenin-labelled DNA probe were com-; pared with two Standard Hepatitis B virus DNA probes, synthesized with cloned Hepatitis B virus DNA and labelled either with digoxigenin or 32 P by random priming. Data obtained from the three methods showed an excellent correlation.
Introduction
cation of the desired DNA fragment from an hetero-_. _, .. ^ .
-" . , geneous mixture of serum DNAs. The detection of hepatitis B virus DNA m serum by spot-blot hybridization is an indication of viral repli-In this report we describe a method for synthesizing cation and correlates with the patient's infectivity and specific DNA probes which use DNA extracted from hepatic inflammatory activity (1) (2) (3) . Although the the serum of an hepatitis B virus carrier äs target, and widely-used detection of DNA by isotopic probes is digoxigenin-11-2^deoxyuridine-5'-triphosphate (digoxihighly sensitive, its use in clinical diagnosis is limited genin-11-dUTP) incorporated during polymerase chain economically by the need for special facilities. For this reaetion, äs tracer. We compare the results obtained with reason, non-isotopic probes have been proposed äs an this probe with those obtained with two hepatitis B virus alternative (4) . Recently, ä new non-radioactive System DNA probes (both from Eco RI fragment isolated from was developed, which uses digoxigenin for labelling pCFSO plasmid containing four copies of cloned hepa-DNA probes (5) (6) . Digoxigenin can be incorporated titis B virus DNA), labelled either with digoxigenin or into a fragment of DNA by random priming or during 32 P by random priming, in serum samples from patients the polymerase chairi reaction (7) . This last method has with chronic hepatitis B. the advantage that DNA from serum may be used äs target (8) instead of cloned DNA, because the specificity of the polymerase chain reaction allows the amplifi-Materials and Methods titis was based on cvidcncc of persistent alteration in hepatic tests for longer than six months, and the presence of chronic hepatitis in an histological examination.
Group II consisted of 30 healthy blood donors without serological markers of hepatitis B vims infection.
Serological assays
Sera were evaluated for HBsAg, anti-HBs, anti-HBc, HBeAg, and anti-HBe by commercial radioimmunoassay kits: Ausria-II, Ausab, Corab, Abbott HBe (Abbott Laboratories, North Chicago, IL).
Purification and DNA labelling by polymerase chain reaction Hepatitis B virus DNA was purified and extracted from serum samples s previously described (9): digestion with proteinase K, and extraction with phenol (once) and with chloroform/isoamylalcohol (twice). Subsequently, the hepatitis B virus DNA was precipitated with ethanol in the presence of sodium acetate. For the polymerase chain reaction assay, a set of sequences 20 nucleotides long, specific for the hepatitis B virus pre-core/core region, was synthesized and used s primers: Primer 1765, 5TCTTTGTAC-TAGGAGGCTGT begins atposition 1765 of the hepatitis B virus genome and primer 2458, 5'CTAACATTGAGATTCCCGAG (from the complementary or reverse DNA Strand) begins at map position 2458 (10) . The size of the amplified product is 694 base pairs. The polymerase chain reaction was performed according to the protocol ofSaiki et al. (11) with some modifications. Reactions were carried out in a volume of 100 μΐ containing at least 10-20 pg of hepatitis B virus DNA from serum, 200 μηιοΙ/1 of each deoxynucleotide triphosphate (dATP, dCTP, dGTP) including dTTP (165 μπιοΐ/ΐ) partially substituted with digoxigenin-11-dUTP (35 μηιοΐ/ΐ), 50 pmol of each primer and 2.5 U of Taq thermostable polymerase (Boehringer Mannheim), in a buffer containing 50 mmol/1 KC1, 10 mmol/1 Tris-HCl (pH 8.3) and 1.5 mmol/1 MgCl 2 -The reaction was performed for 35 cycles (1min 94 °C, 1min 60 °C and 3min 72 °C) in a programmable DNA Thermal Cycler (Perkin Eimer Cetus). The specificity of the amplified product was confirmed by Southern blot hybridization, using 32 P labelled hepatitis B virus DNA (isolated from pCF80) s probe. The sensitivity of the digoxigenin DNA probe was determined by testing decreasing dihitions (500 to 0.5 pg) of plasmid DNA pCF80 in duplicate. As negative control, plasmid pBR322 at a concentration of 200 pg was used.
To confirm the gene-specificity of the probe, another specific probe from the Pre-S/S region was synthesized by a similar procedure, and a crossed-hybridization experiment was designed in which three parallel polymerase chain reaction techniques were used to amplify three difFerent hepatitis B virus DNA fragments: one from the Pre-core/core region (694 base pairs), another from the Pre-S/S gene (567 base pairs) and a third which included a combiiiation of both regions (1.9 X l O 3 base pairs). After Southern blot transfer, all three amplification products were hybridized separately with each specific probe. Serum samples from healthy subjects who tested negative for hepatitis B virus markers were used s controls. The rate of labelling was tested in the non-isotopic probes by seriaL dilutions of each probe spotted on nylon membrane, followed by colour reaction.
Hepatitis B virus DNA assay
The spot-blot hybridization technique described by Scotto et al. (3) for the detection of hepatitis B virus DNA was used with minor modifications (12) . Seven microlitres of each sample were directly denatured in 0.5 mol/1 NaOH, 1.5 mmol/I NaCl for 10 min, and transferred by vacuum to a nylon membrane (Hybond-N. Amersham). The nylon filters were always, prehybridized for at least 2 h in 12.5 mol/1 formamide, saline/s dium citrate (0.75 raol/1 NaCl, 0.075 mol/1 Na-citrate), 0,02 mol/1 Na-phosphate (pH 6.5), Denhardfs solution (0.1 g/l Ficoll (type 400, Pharmacia), 0.1 g/l polyvinylpyrrolidone and 0.1 g/l bovine serum albumin (fraction V, Sigma)) and 100 mg/1 salmon sperm DNA at 42 °C. Hybridization was carried out in the same solution with either 100 μ^Ι of non-radioactive probe or 10 μg/l of radioactive probe.
The positive hybridization with digoxigenin-labelled probes was visualized by enzyme-linked immunoassay using an antibody-conjugate (antidigoxigenin alkaline phosphatase conjugate) and nitroblue tetrazolium/5-bΓomo-4-chloror3-indolyl·phosphate s colour Substrates following the supplier's iristructipns (Boehringer Mannheim) (6) . Positive hybridizations with the radioactive probe was detected by autoradiography (14h at -70 °C) with Kodak XAR-S film and Micron R intensifying screen.
The sensitivity of the two probes synthesized with cloned hepatitis B virus DNA is 0.5 pg s previously described (12) .
Results

DNA labelling by polymerase chain reaction
The polymerase chain reaction products were analysed by agarose gel electrophoresis. The fragment obtained without digoxigenin produced a clear band of 694 base pairs corresponding to the expected length of the ampll·· fied region. The lower electrophoretic mobility of the polymerase chain reaction products with digoxigenin indicated that his hapten had been incorporated into the DNA fragment with a resulting increase in molecular mass ( fig. 1 ). The differences in mobility between the normal and the digoxigenin-labelled polymerase chain reaction fragments permit an approximate estimate (derived from a seinilog rithmic representation of mobility vs. molecular mass, using the molecular m ss markers for the Standard curve) of the number of hapten molecules incorporated (11-12 per probe molecule). This estimate may be utilized s a first control to validate the labelling process, in addition to the above described dilution method. The dilution method detected up to 10~6 dilutions of the original polymerase chain reaction probe solution.
Specificity and sensitivity of the serum hepatitis B virus DNA probe synthesized by polymerase chain reaction
The specificity of the polymerase chain reaction probes was tested by dot and Southern blot hybridization, using previously tested samples, which were positive for HBeAg and hepatitis B virus»DNA, s positive controls. Patients from group II were used äs negative controls. None of the negative controls produced positive Signals. Some examples are shown in figure 2 (absence of hybridization Signals in the negative lanes of Southern blots) and in figure 3 (coordinates el, e2, e3 and e4 of dot blots).
The specific probes labelled with digoxigenin for the Pre-core/core and Pre-S/S regiöns hybridized exclusively with the amplificatioia products of their respective regiöns. lii neither case was cross-hybridization observed. Moreover, both probes hybridized witb the large amplified hepatitis B virus DNA fragment that included the two regiöns. Neither of the two probes hybridized with the negative controls ( fig. 2 ).
Using spot test hybridization, the digoxigenin polymerase chain reaction-labelled probe detected äs little äs 0.5 pg of cloned hepatitis B virus, which is comparable to the sensitivity obtained with random priming probes (12) .
Comparison of hybridization results
The results from the serum digoxigenin polymerase chain reaction incorporated probe were compared with results from the cloned hepatitis B virus DNA probes labelled either with digoxigenin or 32 P by random priming. Hepatitis B virus DNA was determined by Spot hybridization in the serum of 150 HBsAg positive patients. Hepatitis B virus DNA was detected in 68 (45%) of the 150 HBsAg positive serum specimen patients: fifty four (90%) from HBeAg positive chronic hepatitis patients, and fourteen (15%) from anti-HBe positive, with all three methods. None of the 30 samples from the healthy subjects was positive for hepatitis B virus DNA by any of the three techniques. In some samples with positive hybridization Signals the observed intensity was higher in the non-radioactive methods than the radioactive one, showing additionally a slightly different colour from that expected. Sometimes it was necessary to overexpose a filter in order to assure the presence of weak hybridization Signals. As an example of the hybridization comparison, figure 3 shows a dot blot experiment including a sample group of patients randomly selected from the study population.
Discussion
The synthesis of DNA probes from human serum using the polymerase chain reaction technique has not been described previously. In this study, DNA extracted from the serum of hepatitis B virus carriers was used äs the target. By including a modified nucleotide with digoxigenin äs the tracer in the amplification mixture of a Standard polymerase chain reaction, specific non-radioactive probes for determining hepatitis B virus DNA by spothybridization were produced.
In the dot blot experiments (see fig. 3 ) the results obtained with serum probes are the same äs those obtained with the Standard probes with respect to the subsequent clinical decision (i. e. positivity or negativity). In some samples, however, differences in the intensity of the hybridization Signals were observed between the radioactive and the non-radioactive probes, the latter giving more intense Signals than the former. These anomalous Signals present a slightly different colour from those remaining, which may have been produced by some unknown interference present in the original serum samples. The results obtained in the Southern blot experiment confirmed the expected specificity of the serum polymerase chain reaction probes and disclosed a characteristic property of polymerase chain reaction probes (from serum or cloned DNA) that can be called "sequence-specificity", based on the ability of the polymerase chain reaction process to produce concrete DNA P-labelled probe. Filter B was hybridized with a digoxigenin-labelled probe synthe-. sized by random priming using cloned hepatitis B virus DNA s target.
Filter C was hybridized with a digoxigenin-labelled probe syntheŝ ized <by polymerase chain reaction with hepatitis B virus DNA extracted from human serum. Non-radioactive hybridizations were detected by the colorimetric method (see text). Positive controls were spotted in positions e5, e6 and e7; and negative ones in positions el, e2, e3 and' e4. fragments defined by the selected set of primers. We demonstrated this property in the experiment shown in figure 2 . A possible application of this property could be the study of which genes are present in the partially inserted hepatitis B virus DNA sequences observed within the hepatocyte genome of asymptomatic hepatitis B virus carriers or in hepatocellular carcinomas. Such a study could be carried out using subcloned fragments of hepatitis B virus DNA äs gene-specific probes, but the protocol would be much more complex than in the method suggested above.
These results demonstrate that the sensitivity, specificity and analytical applications of these probes are the same äs those of conventional probes, prepared with cloned DNA. Since they are synthesized with an amplification process specific for a sequence of target DNA, the serum probes may be used for detecting complete genomes, äs well äs a particular sequence in heterogeneous DNA mixtures.
The described method offers a number of methodological advantages over the conventional techniques presently used. The characteristics of the polymerase chain reaction reaction permit the use of DNA from hepatitis B virus DNA present in the serum of an HBsAg-positive patient, despite the complexity of this serum DNA, which is a mixture of viral and human DNAs. Labelling with digoxigenin permits the synthesis of large quantities of probe which may be stored at least one year without losing activity. Moreover, this non-radioactive method avoids the inconveniences of radioactive isotopes which have short half-lives and are difficult to handle in a routine diagnosis laboratory.
Finally, the technology necessary for synthesizing this type of probe is simple and may be easily implemented in the clinical laboratory. The need for specialized equipment, trained personnel and the extra time to carry out molecular biology techniques such äs cloning, cellular transformation or vector amplification, is completely eliminated.
The resuits obtained from this study suggest that digoxigenin-labelled serum DNA probes may be a valid and practical alternative to probes obtained from cloned DNA.
